FABP4‐mediated lipid droplet accumulation drives epithelial–mesenchymal transition and aggravates alveolar epithelial barrier disruption
Clinical and Translational Medicine · 2026-01 · 16 (1)
DOI: 10.1002/ctm2.70563 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 26.12.2025. Verfasst von Zihao Shen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Fatty Acid-Binding Proteins, Epithelial-Mesenchymal Transition, Lipid Droplets. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: by National Natural Science Foundation of China, Postgraduate Research & Practice Innovation Program of Jiangsu Province, the Jiangsu High-level Hospital Pairing Assistance Research Initiative.
Abstract (Originalsprache)
Background
Acute respiratory distress syndrome (ARDS) frequently develops after cardiopulmonary bypass (CPB), with lung ischemia/reperfusion injury (LIRI) as a major contributing factor. However, the role of fatty acid‐binding protein 4 (FABP4) in the pathogenesis of CPB‐associated ARDS remains poorly understood.
Methods
Experimental LIRI models were established in vivo and in vitro to investigate the role of FABP4 in alveolar epithelial injury. Lipid droplets (LDs) accumulation, fatty acid (FA) metabolism, epithelial‐mesenchymal transition (EMT), and alveolar epithelial barrier (AEB) integrity were assessed using molecular, cellular, and functional approaches. Pharmacological and genetic interventions were applied to evaluate the contribution of FABP4‐mediated signaling pathways.
Results
LIRI induced autocrine FABP4 signaling in alveolar epithelial cells, leading to pronounced LDs accumulation and disruption of AEB integrity. FABP4 activation enhanced FA metabolism and promoted EMT, which played a critical role in epithelial barrier dysfunction. Mechanistically, FABP4 activated the p38 MAPK pathway, resulting in ULK1 phosphorylation, suppression of lipophagy, and subsequent LDs formation, thereby driving EMT. Inhibition of LDs accumulation effectively attenuated EMT and alleviated AEB disruption.
Conclusion
FABP4 serves as a key metabolic regulator linking lipid reprogramming to EMT and alveolar epithelial barrier disruption during LIRI. Targeting FABP4‐mediated lipid metabolism may represent a promising therapeutic strategy for preventing ARDS following CPB. Key points LIRI induces autocrine FABP4 signaling in alveolar epithelial cells. FABP4 promotes lipid droplets accumulation by inhibiting lipophagy through p38 MAPKULK1 signaling. FABP4‐driven lipid metabolic reprogramming triggers EMT and disrupts alveolar epithelial barrier integrity. Targeting FABP4 or lipid droplets accumulation may offer therapeutic potential for CPB‐associated ARDS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
- Department of Cardiothoracic Surgery, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, Jiangsu, China.
ORCID-Profile: Peng Lu
Förderung
- by National Natural Science Foundation of China
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
- the Jiangsu High-level Hospital Pairing Assistance Research Initiative
Zitieren
APA
Shen, Z., Qi, Y., Chu, M., Wu, M., Feng, C., Li, X., Liu, Z., Si, L., Wang, Y., Zhang, J., Lu, X., & Lu, P. (2026). FABP4‐mediated lipid droplet accumulation drives epithelial–mesenchymal transition and aggravates alveolar epithelial barrier disruption. Clinical and Translational Medicine, 16(1). https://doi.org/10.1002/ctm2.70563
Vancouver
Shen Z, Qi Y, Chu M, Wu M, Feng C, Li X, et al. FABP4‐mediated lipid droplet accumulation drives epithelial–mesenchymal transition and aggravates alveolar epithelial barrier disruption. Clinical and Translational Medicine. 2026;16(1). doi:10.1002/ctm2.70563
BibTeX
@article{Shen2026,
author = {Shen, Zihao and Qi, Yuanpu and Chu, Mingyu and Wu, Minchao and Feng, Chen and Li, Xiangyu and Liu, Zhaoyang and Si, Linjie and Wang, Yongliang and Zhang, Jialin and Lu, Xiaoning and Lu, Peng},
title = {FABP4‐mediated lipid droplet accumulation drives epithelial–mesenchymal transition and aggravates alveolar epithelial barrier disruption},
journal = {Clinical and Translational Medicine},
year = {2026},
volume = {16},
number = {1},
doi = {10.1002/ctm2.70563}
}
EUVIMED